000 | 00971 a2200277 4500 | ||
---|---|---|---|
005 | 20250518053656.0 | ||
264 | 0 | _c20200228 | |
008 | 202002s 0 0 eng d | ||
022 | _a1090-2430 | ||
024 | 7 |
_a10.1016/j.expneurol.2019.113032 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMuir, E | |
245 | 0 | 0 |
_aRecent advances in the therapeutic uses of chondroitinase ABC. _h[electronic resource] |
260 |
_bExperimental neurology _c11 2019 |
||
300 |
_a113032 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aChondroitin ABC Lyase _xtherapeutic use |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aSpinal Cord Injuries _xtherapy |
700 | 1 | _aDe Winter, F | |
700 | 1 | _aVerhaagen, J | |
700 | 1 | _aFawcett, J | |
773 | 0 |
_tExperimental neurology _gvol. 321 _gp. 113032 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.expneurol.2019.113032 _zAvailable from publisher's website |
999 |
_c29991508 _d29991508 |